rs6080
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000236.3(LIPC):c.575-8C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0338 in 1,613,420 control chromosomes in the GnomAD database, including 1,069 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000236.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPC | NM_000236.3 | c.575-8C>A | splice_region_variant, intron_variant | ENST00000299022.10 | NP_000227.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPC | ENST00000299022.10 | c.575-8C>A | splice_region_variant, intron_variant | 1 | NM_000236.3 | ENSP00000299022.5 |
Frequencies
GnomAD3 genomes AF: 0.0257 AC: 3910AN: 152224Hom.: 71 Cov.: 34
GnomAD3 exomes AF: 0.0281 AC: 7047AN: 250942Hom.: 133 AF XY: 0.0294 AC XY: 3990AN XY: 135698
GnomAD4 exome AF: 0.0347 AC: 50665AN: 1461080Hom.: 998 Cov.: 34 AF XY: 0.0349 AC XY: 25394AN XY: 726912
GnomAD4 genome AF: 0.0257 AC: 3908AN: 152340Hom.: 71 Cov.: 34 AF XY: 0.0252 AC XY: 1874AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hyperlipidemia due to hepatic triglyceride lipase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at